APRICUS BIOSCIENCES INC - COM NEW (APRI)

CUSIP: 03832V307

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM NEW
Total 13F shares
5,493,695
Share change
-135,111
Total reported value
$1,055,134
Price per share
$0.19
Number of holders
15
Value change
-$69,777
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 03832V307?
CUSIP 03832V307 identifies APRI - APRICUS BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APRICUS BIOSCIENCES INC - COM NEW (APRI) as of Q4 2018

As of 31 Dec 2018, APRICUS BIOSCIENCES INC - COM NEW (APRI) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,493,695 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, ARDSLEY ADVISORY PARTNERS LP, CITADEL ADVISORS LLC, BlackRock Inc., UBS Group AG, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and Frontier Wealth Management LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.